April 17, 2024
TOPLINE: Guselkumab shows early and durable improvement in joint symptoms, spinal pain, and skin clearance through 2 years in biologic-naive patients with active psoriatic arthritis (PsA), […]
April 16, 2024
TOPLINE: An analysis of molecular-targeted cancer drug therapies recently approved in the United States found that fewer than one third demonstrated substantial clinical benefits at the […]
April 16, 2024
TOPLINE: Among people with type 2 diabetes (T2D) using insulin, sodium-glucose cotransporter 2 inhibitors (SGLT2is) were associated with a reduced risk for diabetic macular oedema (DMO) […]
April 16, 2024
TOPLINE: Continuous glucose monitoring (CGM) data provide a more comprehensive characterization of glucose values than fasting glucose (FG) measurement alone. Considerable FG variability was seen even […]
April 16, 2024
TOPLINE: Botulinum toxin (BTX) and dermal fillers are safe as cosmetic and antiaging treatments in individuals with skin of color (SOC), with the largest amount of […]
April 16, 2024
TOPLINE: Biscuits reformulated with the sweeteners and sweetness enhancers (S&SEs) neotame and stevia rebaudioside M (StRebM) yield similar appetite responses as sucrose-sweetened ones but decrease post-meal […]
April 15, 2024
TOPLINE: Combined pediatric dermatology-rheumatology clinics can improve patient care and patient satisfaction, a survey of dermatologists suggested. METHODOLOGY: Combined pediatric dermatology-rheumatology clinics can improve patient outcomes […]
April 15, 2024
TOPLINE: A low-fat vegan diet — high in fiber and carbohydrates and moderate in protein — reduces insulin requirement, increases insulin sensitivity, and improves glycemic control […]
April 15, 2024
TOPLINE: Implementing the Opioid Overdose Recovery Program (OORP) in emergency departments (EDs) boosts medication for opioid use disorder ( MOUD) initiation and reduces repeat overdoses, with […]